Gedeon Richter Pledges New Markets For Teriparatide Biosimilar
Debuted In Three New Markets In Last 12 Months
Gedeon Richter aims to continue the global roll-out of its teriparatide biosimilar, having enjoyed continued solid growth for the Forsteo rival during the first quarter.
